These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34172076)

  • 21. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A; El-Menshawe S; Afouna M
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silybin-Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress.
    Federico A; Dallio M; DI Fabio G; Zarrelli A; Zappavigna S; Stiuso P; Tuccillo C; Caraglia M; Loguercio C
    In Vivo; 2015; 29(5):569-75. PubMed ID: 26359416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin.
    Tung NT; Tran CS; Nguyen HA; Nguyen TD; Chi SC; Pham DV; Bui QD; Ho XH
    Int J Pharm; 2019 Jan; 555():63-76. PubMed ID: 30448315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study on the stability of silybin and that in silymarin in buffers and biological fluids.
    Tang N; Wu D; Lu Y; Chen J; Zhang B; Wu W
    Drug Metab Lett; 2009 Apr; 3(2):115-9. PubMed ID: 19601873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Separation and determination of effective components in silymarin and preparations of silymarin by MECC].
    Ding TM; Tian SJ; Zhang ZX; Shi YH; Sun ZP
    Yao Xue Xue Bao; 2000 Oct; 35(10):778-81. PubMed ID: 11372447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
    Woo JS; Kim TS; Park JH; Chi SC
    Arch Pharm Res; 2007 Jan; 30(1):82-9. PubMed ID: 17328246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bioavailability of metoclopramide in soft-gel capsules and tablets in healthy volunteers].
    Rapelli S
    Clin Ter; 1986 Nov; 119(3):219-25. PubMed ID: 3802734
    [No Abstract]   [Full Text] [Related]  

  • 28. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.
    Yanyu X; Yunmei S; Zhipeng C; Qineng P
    Int J Pharm; 2006 Jan; 307(1):77-82. PubMed ID: 16300915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silybin and silymarin--new and emerging applications in medicine.
    Gazák R; Walterová D; Kren V
    Curr Med Chem; 2007; 14(3):315-38. PubMed ID: 17305535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism, Transport and Drug-Drug Interactions of Silymarin.
    Xie Y; Zhang D; Zhang J; Yuan J
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31615114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phytosome-nanosuspensions for silybin-phospholipid complex with increased bioavailability and hepatoprotection efficacy.
    Chi C; Zhang C; Liu Y; Nie H; Zhou J; Ding Y
    Eur J Pharm Sci; 2020 Mar; 144():105212. PubMed ID: 31923602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells.
    Kumar N; Rai A; Reddy ND; Raj PV; Jain P; Deshpande P; Mathew G; Kutty NG; Udupa N; Rao CM
    Pharmacol Rep; 2014 Oct; 66(5):788-98. PubMed ID: 25149982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive effects of different drug forms of silybin in the treatment of metabolic syndrome.
    Poruba M; Matušková Z; Kazdová L; Oliyarnyk O; Malínská H; Tozzi di Angelo I; Večeřa R
    Physiol Res; 2015; 64(Suppl 4):S507-12. PubMed ID: 26681080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bioavailability of silymarin, 3: splitting of silybin dihemisuccinate by plasma and liver esterases].
    Koch H; Tscherny J
    Arch Pharm (Weinheim); 1983 May; 316(5):426-30. PubMed ID: 6870500
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative study of the hepatoprotective effect of silymarin and silybin on isolated rat hepatocytes.
    Miguez MP; Anundi I; Sainz-Pardo LA; Lindros KO
    Toxicol In Vitro; 1994 Aug; 8(4):581-3. PubMed ID: 20692965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving bioavailability of silybin by inclusion into SBA-15 mesoporous silica materials.
    Fu T; Lu J; Guo L; Zhang L; Cai X; Zhu H
    J Nanosci Nanotechnol; 2012 May; 12(5):3997-4006. PubMed ID: 22852339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the Effect of Silybin and Silybin Advanced™ on Viability and HER2 Expression on the Human Breast Cancer SKBR3 Cell Line by no Serum Starvation.
    Mahmoodi N; Motamed N; Paylakhi SH; O Mahmoodi N
    Iran J Pharm Res; 2015; 14(2):521-30. PubMed ID: 25901160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparative chromatographic purification of diastereomers of silybin and their quantification in human plasma by liquid chromatography-tandem mass spectrometry.
    Li W; Han J; Li Z; Li X; Zhou S; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 862(1-2):51-7. PubMed ID: 18054294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability and pharmacokinetics of ampicillin and amoxycillin from tablets, capsules and long-acting preparations in the homing pigeon (Columba livia).
    Dorrestein GM; van Gogh H; Rinzema JD; Buitelaar MN
    J Vet Pharmacol Ther; 1986 Dec; 9(4):394-401. PubMed ID: 3806780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the nanotechnology-based drug delivery of Silybin.
    Wang Y; Zhang L; Wang Q; Zhang D
    J Biomed Nanotechnol; 2014 Apr; 10(4):543-58. PubMed ID: 24734507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.